06/30 - 02:15 PM ET
MERCK UP 2.4% AT $37.88; LEADS DOW INDUS. COMPONENTS IN PERCENTAGE GAIN
06/27 - 11:02 AM ET
MERCK: TELCAGEPANT IMPROVED MIGRAINE SYMPTOMS IN PHASE III STUDY
06/27 - 08:06 AM ET
MERCK TO PAY SCHERING-PLOUGH $105M FROM JOINT VENTURE TERMINATION
06/25 - 08:56 AM ET
MERCK REITERATES CONFIDENCE IN DOUBLE-DIGIT COMPOUND ANN EPS GRWTH FROM 2005-10
06/25 - 08:55 AM ET
MERCK REITERATES CONFIDENCE IN 4-6% COMPOUND ANN REV GROWTH GOAL FROM 2005-10
06/25 - 08:54 AM ET
MERCK: FDA LETTER DOESN'T AFFECT GARDASIL INDICATION IN FEMALES 9-26
06/25 - 08:53 AM ET
MERCK : HAS ALREADY DISCUSSED QUESTIONS WITH FDA RELATED TO APPLICATION
06/25 - 08:53 AM ET
MERCK: EXPECTS TO RESPOND TO FDA IN JULY
06/25 - 08:52 AM ET
MERCK LETTER: ISSUES PRECLUDE APPROVAL OF SUPPLEMENT IN EXPECTED TIMEFRAME
06/25 - 08:51 AM ET
MERCK LETTER SAYS FDA HAS COMPLETED SUBMISSION REVIEW
06/25 - 08:50 AM ET
MERCK GETS COMPLETE RESPONSE LETTER FROM FDA FOR GARDASIL IN WOMEN 27-45